Cinsebrutinib
Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6) . Cinsebrutinib has the potential for cancer study.
Product Specifications
CAS Number
2724962-58-5
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cinsebrutinib.html
Solubility
10 mM in DMSO
Smiles
FC1=CC(C(N)=O)=C(NC2=C3CCCCC2)C3=C1[C@H]4CN(CCC4)C(C=C)=O
Molecular Formula
C22H26FN3O2
Molecular Weight
383.46
References & Citations
[1]Coburn, Craig Alan, et al. Preparation of pyridoindolecarboxamides and their analogs as BTK kinase inhibitors. WO2021207549.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
7-07269 1000 µg
Recombinant Hepatitis C Virus NS3 Genotype-3 (1356-1459)
Sign In for Pricing
View Details 
bs-3889R-BF555-01 20 µL
NOX2 Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details bs-3889R-BF555-02 100 µL
NOX2 Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details